Piper Sandler lowered the firm’s price target on UnitedHealth (UNH) to $353 from $552 and keeps an Overweight rating on the shares. The firm cites a 15-times multiple of lower CY26 adjusted EPS that contemplates both the company’s considerable execution risk and its uniquely capable management team. Piper notes CEO Stephen Hemsley promised reliability, excellence and transparency in brief remarks at the Annual Shareholder Meeting. Repricing at UnitedHealth is the first step in a 3-year turnaround.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on UNH:
- UnitedHealth (UNH) Shareholders Approve CEO’s $60M Stock Award amid Uncertainty
- ‘Only the Beginning,’ Says Top Investor About UnitedHealth Stock
- ‘Time to Load Up,’ Says KeyBanc About UnitedHealth Stock
- UnitedHealth (UNH) Looks to Win Back Investor Trust as Analysts Cut Price Targets
- BofA says UnitedHealth comments imply some pressure in commercial book of biz